Search

Your search keyword '"Karen Chung"' showing total 5 results
Start Over Author "Karen Chung" Journal value in health
5 results on '"Karen Chung"'

1. PCN262 PREFERENCE-WEIGHTED HEALTH STATUS IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL) TREATED WITH LISOCABTAGENE MARALEUCEL (LISO-CEL; JCAR017) IN THE ONGOING, MULTICENTER, PHASE 1 TRANSCEND NHL 001 TRIAL

Author

C. Dehner, Donald L. Patrick, Karen Chung, J. Garcia, Y. Kim, and L. Matza

Subjects
Oncology, medicine.medical_specialty, business.industry, Health Policy, Internal medicine, Relapsed refractory, Public Health, Environmental and Occupational Health, medicine, In patient, medicine.disease, business, Diffuse large B-cell lymphoma, Preference
Published
2019
Full Text
View/download PDF

2. Treatment Practice Patterns, Healthcare Resource Utilization (HRU), and Costs in Newly Diagnosed Patients with Therapy-Related Acute Myeloid Leukemia (TAML) or AML with Myelodysplasia-Related Changes (AML-MRC) in a United States (US) Commercially Insured Population

Author

M Hagiwara, A Sharma, Karen Chung, and Thomas E. Delea

Subjects
medicine.medical_specialty, education.field_of_study, business.industry, Health Policy, Population, Public Health, Environmental and Occupational Health, Newly diagnosed, Therapy-Related Acute Myeloid Leukemia, Internal medicine, Treatment practice, Health care, medicine, business, education, Resource utilization
Published
2018
Full Text
View/download PDF

3. PCN132 MODELING THE LIFETIME EFFECTIVENESS OF DENOSUMAB AND ZOLEDRONIC ACID (ZA) IN THE PREVENTION OF SKELETAL RELATED EVENTS (SRE) IN PATIENTS WITH BONE METASTASES FROM SOLID TUMORS

Author

A. Bracco, Mark D. Danese, M Lothgren, D. Macarios, Karen Chung, Arie Barlev, and M. Halperin

Subjects
Oncology, medicine.medical_specialty, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Skeletal related events, Surgery, Denosumab, Zoledronic acid, Internal medicine, medicine, In patient, business, medicine.drug
Published
2011
Full Text
View/download PDF

4. PCN116 Cost-Effectiveness of Denosumab Versus Zoledronic Acid (ZA) for the Prevention of Skeletal-related Events (SRE) in Patients with Bone Metastases from Solid Tumors in the Netherlands

Author

Karen Chung, M. Halperin, A. Bracco, D. Macarios, Mark D. Danese, B. Lucius, M Lothgren, and K. Northridge

Subjects
Oncology, medicine.medical_specialty, Cost effectiveness, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Skeletal related events, Surgery, Denosumab, Zoledronic acid, Internal medicine, medicine, In patient, business, medicine.drug
Full Text
View/download PDF

5. PCN26 BUDGET IMPACT MODEL OF DENOSUMAB FOR SKELETAL RELATED EVENT (SRE) PREVENTION IN PATIENTS WITH BREAST AND PROSTATE CANCER

Author

Karen Chung, Mark D. Danese, M. Halperin, K. Northridge, and A. Richhariya

Subjects
Oncology, medicine.medical_specialty, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Skeletal related events, Budget impact, medicine.disease, Prostate cancer, Denosumab, Internal medicine, hemic and lymphatic diseases, medicine, In patient, business, medicine.drug
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results